The Approval of a New Malaria Vaccine and Vaccine Effectiveness

Discussion on the approval of a new malaria vaccine, its significance, and frustration with its naming. Highlighted are the challenges of developing a vaccine for a parasite, the use of advanced market commitments to incentivize pharmaceutical companies, and the success of vaccines in combating diseases like pneumococcus. Also covered are the effectiveness of the RTS, S vaccine in reducing child deaths and severe malaria, the modest effectiveness of COVID vaccines, and the role of organizations like Gavi in vaccine distribution.